Your browser doesn't support javascript.
loading
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.
Lecoq, Inés; Kopp, Katharina L; Chapellier, Marion; Mantas, Panagiotis; Martinenaite, Evelina; Perez-Penco, Maria; Rønn Olsen, Lars; Zocca, Mai-Britt; Wakatsuki Pedersen, Ayako; Andersen, Mads Hald.
Afiliação
  • Lecoq I; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.
  • Kopp KL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Chapellier M; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.
  • Mantas P; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.
  • Martinenaite E; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Perez-Penco M; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.
  • Rønn Olsen L; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Zocca MB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Wakatsuki Pedersen A; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Andersen MH; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.
Oncoimmunology ; 11(1): 2115655, 2022.
Article em En | MEDLINE | ID: mdl-36052217

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article